Design and Activity of a Murine and Humanized anti-CEACAM6 scFv in the Treatment of Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDA) is a lethal disease with surgery the only curative modality for localized disease; gemcitabine with or without erlotinib remains standard therapy for unresectable or metastatic disease. CEACAM6 is over-expressed in human PDA independent of stage or grade, and c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Riley, Christopher J., Engelhardt, Kevin P., Saldanha, Jose W., Qi, Wenqing, Cooke, Laurence S., Zhu, Yingting, Narayan, Satya T., Shakalya, Kishore, Croce, Kimiko Della, Georgiev, Ivan G., Nagle, Raymond B., Garewal, Harinder, Von Hoff, Daniel D., Mahadevan, Daruka
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2672909/
https://ncbi.nlm.nih.gov/pubmed/19244123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-08-2707
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars